Head-to-head trial data comparing oral and injectable options is still emerging, and the right choice will depend on individual patient factors including adherence patterns, tolerability, and cost
The market is inclusive of branded GLP-1 products such as semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Tambin te puede interesar: Trump se atribuye abatimiento de 'El Mencho': 'Lo hemos derrocado' Qu enfermedad padeca El Mencho
They may reduce appetite, increase feelings of fullness, and improve glycemic control
This article will discuss the benefits, risks, and key considerations, helping you decide if this procedure is right for you